Mesh-Augmented Ventral Hernia Repair Despite Iatrogenic -Peritonitis Due to Progressive Pneumoperitoneum: A Case Report.

Surgical case reports 2025 Vol.11(1)

Klewitz R, Menzel M, Holzner P, Fichtner-Feigl S, Hipp J

관련 도메인

Abstract

[INTRODUCTION] Loss-of-domain in large incisional hernia needs to be addressed by mesh-augmented repair combined with a combination of component separation techniques: progressive pneumoperitoneum (PPP) and chemical component separation with botulinum toxin A. In this case report, successful management of an iatrogenic peritonitis caused by PPP with nevertheless definitive treatment of a giant loss-of-domain ventral hernia is presented.

[CASE PRESENTATION] A female patient with M1-3W3 recurrent incisional hernia with a loss-of-domain of 47% was prepared for definitive ventral hernia repair by chemical component separation with botulinum toxin A-infiltration and PPP via an intraperitoneally placed central venous catheter. A significant increase of inflammatory markers was found after 28 days. An emergency CT scan was performed, which showed the PPP and perihepatic/perisplenic contrast-enhancing fluid collections. Exploratory laparoscopy and laparotomy revealed no bowel perforation but fibrinous peritonitis due to an iatrogenic PPP-catheter-associated peritonitis. Despite the fibrinous peritonitis, we decided to proceed with definitive ventral hernia repair (Rives-Stoppa-Sublay-Herniotomy with transversus abdominis release (left) and anterior component separation (right), 42 × 30 cm permanent polypropylene mesh). Initial calculated antibiotic treatment was performed with piperacillin/tazobactam. Microbiologic examinations revealed in the intraoperative specimens on postoperative day 1 and the antibiotic treatment was changed to intravenous flucloxacillin for 14 days after surgery. The further hospital stay was uneventful and the patient was discharged on the 20th postoperative day.

[CONCLUSIONS] The presented case demonstrates the possibilities in complex ventral hernia repair to achieve a satisfying outcome for the patients. Even in cases with infectious complications, a single-stage procedure might be performed safely and a complete reconstruction of the abdominal wall might be achieved. The risk of chronic mesh infection in contaminated situations, especially during the presence of , remains uncertain and has to be weighed against possible benefits.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 botulinum toxin 보툴리눔독소 주사 dict 2
해부 PPP → progressive pneumoperitoneum scispacy 1
해부 bowel scispacy 1
해부 fibrinous scispacy 1
해부 anterior scispacy 1
합병증 infection 감염 dict 1
합병증 contrast-enhancing fluid scispacy 1
재료 polypropylene mesh 메쉬 dict 1
약물 PPP → progressive pneumoperitoneum scispacy 1
약물 piperacillin/tazobactam C0250480
piperacillin-tazobactam combination
scispacy 1
약물 flucloxacillin C0016267
floxacillin
scispacy 1
약물 [INTRODUCTION] Loss-of-domain scispacy 1
약물 intravenous flucloxacillin for 14 scispacy 1
약물 [CONCLUSIONS] scispacy 1
질환 hernia C0019270
Hernia
scispacy 1
질환 peritonitis C0031154
Peritonitis
scispacy 1
질환 fibrinous peritonitis C0267753
Fibrinous peritonitis
scispacy 1
질환 ventral hernia C0019326
Ventral Hernia
scispacy 1
질환 infectious complications scispacy 1
질환 chronic mesh infection C0151317
Chronic Infection
scispacy 1
기타 Mesh-Augmented scispacy 1
기타 patient scispacy 1
기타 M1-3W3 scispacy 1
기타 PPP → progressive pneumoperitoneum scispacy 1
기타 transversus abdominis scispacy 1
기타 patients scispacy 1
기타 abdominal wall scispacy 1

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문